Evogene six-month loss widens to USD 7.66 million; revenue drops 76%
Operating loss widened to USD 5.39 million. Cash and cash equivalents fell to USD 9.32 million at June 30, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.